GLP-1 Medications Primarily Reduce Fat, Not Muscle Mass
GLP-1 meds cause significant fat loss with minimal muscle loss over 12 months, proving their weight management efficacy.
02 May 2026
GLP-1 meds cause significant fat loss with minimal muscle loss over 12 months, proving their weight management efficacy.
GLP-1 study reports semaglutide preserved lean mass better than tirzepatide, with a 2% higher lean mass loss on tirzepatide over 12 months.
